In a landmark achievement for global public health, the World Health Organization (WHO) has officially validated Algeria as having eliminated trachoma as a public health problem. This milestone marks a transformative moment for the North African nation, which becomes the 10th country in the WHO African Region and the 29th globally to reach this significant public health objective.
Trachoma, a debilitating eye disease caused by the bacterium Chlamydia trachomatis, has historically been one of the most formidable challenges to ocular health in developing regions. Its elimination in Algeria stands as a testament to decades of persistent political will, strategic public health planning, and the unwavering dedication of generations of medical professionals.
Understanding the Enemy: The Burden of Trachoma
Trachoma remains the world’s leading infectious cause of blindness. While the global landscape is shifting, the disease continues to persist in 30 countries, leaving approximately 1.9 million people visually impaired or blind. Current data suggests that roughly 97 million people across the globe continue to live in endemic areas, remaining at constant risk of the disease.
The transmission of Chlamydia trachomatis is often tied to poor sanitary conditions, spreading through contact with infected eye discharge—whether via fingers, contaminated clothing, or, most notoriously, eye-seeking flies. The clinical progression of the disease is devastating: repeated infections lead to chronic inflammation and scarring of the inner upper eyelid. Eventually, this scarring causes the eyelid to turn inward, a condition known as trachomatous trichiasis (TT). In this state, the patient’s own eyelashes scrape against the eyeball with every blink, causing agonizing pain, corneal opacity, and, if left untreated, permanent blindness.
A Century of Dedication: The Chronology of Success
Algeria’s journey toward this validation is not a recent development; it is the culmination of a century-long public health endeavor. The foundation for this success was laid in 1909 with the establishment of the Pasteur Institute of Algeria, which provided the early infrastructure for infectious disease research.
Post-Independence Momentum
Following Algeria’s independence, the fight against trachoma took on a new nationalistic fervor. Under the leadership of visionaries such as Professor Mohamed Aouchiche, the nation began a systematic approach to ocular health. This was further bolstered in 1974 by the launch of a robust national public healthcare system, which introduced the revolutionary policy of providing free medical services to all citizens, ensuring that the most vulnerable populations had access to necessary care.
The Modern Era and the SAFE Strategy
To accelerate the final push for elimination, Algeria adopted the WHO-recommended "SAFE" strategy. This multifaceted approach is widely regarded as the gold standard in trachoma control:
- S (Surgery): Providing surgical intervention for those suffering from the advanced, blinding stage of the disease (TT).
- A (Antibiotics): Implementing mass drug administration programs to clear the infection within communities.
- F (Facial Cleanliness): Launching nationwide public awareness campaigns to promote hygiene.
- E (Environmental Improvement): Enhancing access to clean water and sanitation to break the cycle of transmission.
Between 2013 and 2015, the Algerian government implemented an intensive three-year acceleration strategy. A National Expert Committee was formed to oversee the specific targeting of 12 southern wilayas (provinces), including Adrar, Laghouat, Biskra, Béchar, Tamanrasset, Ouargla, El Bayadh, Illizi, Tindouf, El Oued, Naama, and Ghardaïa, where the disease had proven most persistent.
Data-Driven Validation: The 2022 Milestone
The road to official validation required rigorous scientific verification. In 2022, the Algerian Ministry of Health, in collaboration with international experts, conducted a series of WHO-compliant surveys. The findings were definitive: the elimination threshold for active trachoma had been met in every province.
While the majority of areas had also reached the threshold for trachomatous trichiasis (TT), three provinces required additional attention. The government responded with a targeted, door-to-door screening and management initiative, ensuring that no individual was left behind. By December 2025, the Ministry of Health submitted a comprehensive dossier to the WHO, providing irrefutable evidence that Algeria had successfully neutralized trachoma as a public health threat.
Official Perspectives: A Victory for Collective Effort
The international community has lauded Algeria’s achievement as a blueprint for other nations struggling with neglected tropical diseases (NTDs).
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, remarked, "Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health, and is rooted in a century-long commitment. This milestone proves that with sustained political will and on-the-ground leadership from committed health professionals, we can eliminate neglected tropical diseases and build a healthier, more resilient future for all."
Echoing these sentiments, Dr. Mohamed Janabi, WHO Regional Director for Africa, emphasized the human impact: "Trachoma devastates individuals and communities profoundly, with blindness or visual impairment causing painful economic and livelihood loss. The milestone by Algeria is a major achievement that transforms the health and well-being of children, women and entire families."
Professor Mohamed Seddik Ait Messaoudene, Algeria’s Minister of Health, framed the achievement as a testament to national resilience: "This achievement represents a collective victory—the fruit of nearly fifty years of national mobilization—and underscores the Algerian State’s unwavering commitment to the health of its population. This success was made possible through the mobilization of all stakeholders, the dedication of health professionals, and the support of key partners."
Implications and Future Vigilance
While this validation marks the end of trachoma as a public health problem in Algeria, the work is not yet finished. The WHO emphasizes that post-validation surveillance is critical. Algeria’s health authorities are currently working with the WHO to maintain robust monitoring, particularly in populations where the disease was previously endemic, to ensure that there is no resurgence.
Algeria’s success is also significant within the broader context of NTDs. This victory marks the 62nd time a country has eliminated at least one NTD globally, and the 23rd time in the WHO African Region. For Algeria, it is a point of immense pride: trachoma is the first of these 21 globally recognized neglected tropical diseases to be completely eradicated as a public health threat within its borders.
The strengths that allowed Algeria to achieve this—a well-functioning school health system, a transparent health information system, and extensive coverage of specialized eye care—now serve as a solid foundation for the country’s future public health initiatives. By prioritizing equitable access to care and improving the living conditions of its citizens, Algeria has demonstrated that even the most persistent, ancient diseases can be defeated through a combination of science, strategy, and political courage.
As the world looks toward the 2030 targets for the eradication of neglected tropical diseases, Algeria stands as a beacon of hope and a practical model for the international community. The elimination of trachoma is not merely a medical success; it is a profound improvement in the quality of life for millions of Algerians, securing a brighter, clearer future for generations to come.
About the Author
